TY  - JOUR
AU  - Lin, Crystal
AU  - Travis, Ruth C
AU  - Appleby, Paul N
AU  - Tipper, Sarah
AU  - Weiderpass, Elisabete
AU  - Chang-Claude, Jenny
AU  - Gram, Inger T
AU  - Kaaks, Rudolf
AU  - Kiemeney, Lambertus A
AU  - Ljungberg, Börje
AU  - Tumino, Rosario
AU  - Tjønneland, Anne
AU  - Roswall, Nina
AU  - Overvad, Kim
AU  - Boutron-Ruault, Marie-Christine
AU  - Manciniveri, Francesca Romana
AU  - Severi, Gianluca
AU  - Trichopoulou, Antonia
AU  - Masala, Giovanna
AU  - Sacerdote, Carlotta
AU  - Agnoli, Claudia
AU  - Panico, Salvatore
AU  - Bueno-de-Mesquita, Bas
AU  - Peeters, Petra H
AU  - Salamanca-Fernández, Elena
AU  - Chirlaque, Maria-Dolores
AU  - Ardanaz, Eva
AU  - Dorronsoro, Miren
AU  - Menéndez, Virginia
AU  - Luján-Barroso, Leila
AU  - Liedberg, Fredrik
AU  - Freisling, Heinz
AU  - Gunter, Marc
AU  - Aune, Dagfinn
AU  - Cross, Amanda J
AU  - Riboli, Elio
AU  - Key, Timothy J
AU  - Perez-Cornago, Aurora
TI  - Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
JO  - International journal of cancer
VL  - 143
IS  - 10
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2018-01924
SP  - 2351 - 2358
PY  - 2018
AB  - Previous in vitro and case-control studies have found an association between the insulin-like growth factor (IGF)-axis and bladder cancer risk. Circulating concentrations of IGF-I have also been found to be associated with an increased risk of several cancer types; however, the relationship between pre-diagnostic circulating IGF-I concentrations and bladder cancer has never been studied prospectively. We investigated the association of pre-diagnostic plasma concentrations of IGF-I with risk of overall bladder cancer and urothelial cell carcinoma (UCC) in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 843 men and women diagnosed with bladder cancer between 1992 and 2005 were matched with 843 controls by recruitment centre, sex, age at recruitment, date of blood collection, duration of follow-up, time of day and fasting status at blood collection using an incidence density sampling protocol. Odds ratios (ORs) and 95
LB  - PUB:(DE-HGF)16
C6  - pmid:29971779
C2  - pmc:PMC6220964
DO  - DOI:10.1002/ijc.31650
UR  - https://inrepo02.dkfz.de/record/141418
ER  -